XFOR — X4 Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(XFOR)

X4 Pharmaceuticals, Inc.

Live chart and latest XFOR stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

XFOR News

X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

Mar 17, 2026 Stock Titan

New X4 hires get stock options priced at $4.13 a share

Apr 1, 2026 Gotrade

X4 Pharmaceuticals, Inc. Common Stock (XFOR) Stock Price Today & Analysis

Jan 9, 2026 Investing.com

Guggenheim initiates X4 Pharmaceuticals stock with buy rating

Mar 9, 2026 Seeking Alpha

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

Mar 3, 2026 Quiver Quantitative

X4 Pharmaceuticals Stock (XFOR) Opinions on $60M Financing and Leadership Shake-Up | XFOR Stock News

Aug 13, 2025 GlobeNewswire

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 1, 2026 Eastern Progress

Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross?

Dec 24, 2025 Yahoo Finance

X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) largest shareholders are individual investors with 52% ownership, institutions own 31%

Jan 18, 2026 24/7 Wall St.

X4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention

Mar 9, 2026 GuruFocus

Guggenheim Initiates Coverage on XFOR with a "Buy" Rating and $1

Mar 9, 2026 Stock Titan

XFOR SEC Filings - X4 Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms

Apr 2, 2026 Seeking Alpha

X4 Pharmaceuticals: Betting On Mavorixafor For Chronic Neutropenia (NASDAQ:XFOR)

Dec 1, 2025 Quiver Quantitative

X4 Pharmaceuticals Completes $155.3 Million Public Offering of Common Stock

Oct 27, 2025 Yahoo Finance

All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy